Evidence map›Paper›PMID 41062528›Full record

ArticleScientific reports2025

Engineering gene drive docking sites in a haplolethal locus in Anopheles gambiae.

Andrea L Smidler, Eryney A Marrogi, Sean Scott, Enzo Mameli, Daniel Abernathy, Omar S Akbari, George M Church, Flaminia Catteruccia, Kevin Esvelt

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Andrea L SmidlerDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. asmidler@gmail.com.
Eryney A MarrogiDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Sean ScottDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Enzo MameliDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
Daniel AbernathyDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
Omar S AkbariDepartment of Cell and Developmental Biology, School of Biological Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
George M ChurchDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Flaminia CatterucciaDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. fcatter@hsph.harvard.edu.
Kevin EsveltMedia Lab, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. esvelt@mit.edu.

Funding

The olfactory basis of locating nectar sugar sources in Aedes aegypti mosquitoesR01AI148300 · NIAID · UNIVERSITY OF WASHINGTON · PI Omar Sultan Akbari, Ronald Jason Pitts · 2021 to 2026
$4.1M
Olfactory modulation of color vision and behavior in mosquitoesR01AI175152 · NIAID · UNIVERSITY OF WASHINGTON · PI Omar Sultan Akbari, Jeffrey A Riffell · 2023 to 2026
$3.2M
Targeting the reproductive interactome of the malaria vector Anopheles gambiaeR01AI104956 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI CATTERUCCIA, FLAMINIA · 2013 to 2017
$3.0M
Precision guided SIT for the control of vector-borne diseaseR01AI151004 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AKBARI, OMAR SULTAN · 2020 to 2024
$2.3M
Sculpting the Enteric Microbiota with CRISPR-Cas SystemsR00DK102669 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESVELT, KEVIN · 2016 to 2017
$496k
Using genome engineering to study mosquito biology and combat malariaF31AI120480 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI SMIDLER, ANDREA LYNELLE · 2016 to 2018
$74k
Burroughs Wellcome Fund IRSA1016432Foundation for the National Institutes of Health AI120480-02Foundation for the National Institutes of Health R00-DK102669-04Foundation for the National Institutes of Health R01AI151004Howard Hughes Medical Institute OPP1158190NIAID NIH HHS F31 AI120480NIAID NIH HHS R01 AI104956NIAID NIH HHS R01 AI148300NIAID NIH HHS R01 AI151004NIAID NIH HHS R01 AI175152NIDDK NIH HHS R00 DK102669
6 · The paper itself

Abstract

Gene drives are selfish genetic elements which promise to be powerful tools in the fight against vector-borne diseases such as malaria. We previously proposed population replacement gene drives designed to better withstand the evolution of resistance by homing through haplolethal loci. Because most mutations in the wild-type allele that would otherwise confer resistance are lethal, only successful drive homing and functional r1 alleles permits the cell to survive. Here we outline the development and characterization of two ΦC31-Recombination mediated cassette exchange gene drive docking lines with these features in Anopheles gambiae, a first step towards construction of robust gene drives in this important malaria vector. We outline adaption of the technique HACK (Homology Assisted CRISPR knockin) to knock-in two docking site sequences into a paired putative haplolethal-haplosufficient (Ribosome-Proteasome) locus, and confirm that these docking lines permit insertion of drive-relevant transgenes. We report the first anopheline proteasome knockouts, and identify ribosome mutants in the process reveal a major lethality and infertility hurdle that such designs must overcome to develop robust drives in the future. Although we do not achieve drive, this work provides a new tool for constructing future evolution-robust drive systems and reveals critical challenges that must be overcome for development of future gene drives designed to target haplolethal loci in anophelines and, potentially, other metazoans.

Indexed as

AnophelesGene Drive TechnologyGenetic EngineeringGenetic LociAnimalsCRISPR-Cas SystemsMosquito VectorsProteasome Endopeptidase ComplexProteasome Endopeptidase Complex

Identifiers

PMID41062528
PMCPMC12508426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.